Avadel Pharmaceuticals Plc (AVDL):企業の財務・戦略的SWOT分析

◆英語タイトル:Avadel Pharmaceuticals Plc (AVDL) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1348
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:54
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アイルランド
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Avadel Pharmaceuticals Plc (AVDL) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Avadel Pharmaceuticals Plc (Avadel), formerly Flamel Technologies SA is a specialty pharmaceutical company, which develops and commercializes drugs for allergy, asthma, central nervous system (narcolepsy), pain, respiratory diseases and diabetes. The company’s products are built on its proprietary polymer-based technologies: Micropump, an oral sustained release microparticles platform, LiquiTime, a Micropump – derived platform for liquid oral products, Trigger Lock, a Micropump – derived platform that enables abuse-resistant modified and controlled release formulations and Medusa that enables controlled release of injectables. It sells products in the US, France and Ireland. The company operates in St. Louis, Missouri and Charlotte in the US. Avadel is headquartered in Dublin, Ireland.

Avadel Pharmaceuticals Plc Key Recent Developments

Mar 12,2020: Avadel Pharmaceuticals reports fourth quarter and full year 2019 financial results
Feb 21,2020: Avadel Pharmaceuticals announces $65 million Private Placement with leading biotech investment funds
Dec 10,2019: Avadel Pharmaceuticals appoints Dr. Mark McCamish to its board of directors
Oct 04,2019: Avadel announces resignation of Kevin Kotler from board of directors

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Avadel Pharmaceuticals Plc – Key Facts
Avadel Pharmaceuticals Plc – Key Employees
Avadel Pharmaceuticals Plc – Key Employee Biographies
Avadel Pharmaceuticals Plc – Major Products and Services
Avadel Pharmaceuticals Plc – History
Avadel Pharmaceuticals Plc – Company Statement
Avadel Pharmaceuticals Plc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Avadel Pharmaceuticals Plc – Business Description
Product Category: Akovaz
Overview
Performance
Product Category: Bloxiverz
Overview
Performance
Product Category: Other
Performance
Product Category: Vazculep
Overview
Performance
Geographical Segment: Ireland
Performance
Geographical Segment: United States
Performance
Avadel Pharmaceuticals Plc – Corporate Strategy
Avadel Pharmaceuticals Plc – SWOT Analysis
SWOT Analysis – Overview
Avadel Pharmaceuticals Plc – Strengths
Avadel Pharmaceuticals Plc – Weaknesses
Avadel Pharmaceuticals Plc – Opportunities
Avadel Pharmaceuticals Plc – Threats
Avadel Pharmaceuticals Plc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Avadel Pharmaceuticals Plc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 12, 2020: Avadel Pharmaceuticals reports fourth quarter and full year 2019 financial results
Feb 21, 2020: Avadel Pharmaceuticals announces $65 million Private Placement with leading biotech investment funds
Dec 10, 2019: Avadel Pharmaceuticals appoints Dr. Mark McCamish to its board of directors
Oct 04, 2019: Avadel announces resignation of Kevin Kotler from board of directors
Aug 09, 2019: Avadel Pharmaceuticals reports second quarter 2019 financial results and provides company update
Aug 01, 2019: Avadel Pharmaceuticals further strengthens clinical and medical team
May 08, 2019: Avadel Pharmaceuticals reports first quarter 2019 financial results
Mar 15, 2019: Avadel Pharmaceuticals reports fourth quarter and full year 2018 financial results
Feb 07, 2019: Avadel Pharmaceuticals clarifies announcement of corporate restructuring
Jan 03, 2019: Avadel Pharmaceuticals announces changes to management team and Board of Directors
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Avadel Pharmaceuticals Plc, Key Facts
Avadel Pharmaceuticals Plc, Key Employees
Avadel Pharmaceuticals Plc, Key Employee Biographies
Avadel Pharmaceuticals Plc, Major Products and Services
Avadel Pharmaceuticals Plc, History
Avadel Pharmaceuticals Plc, Subsidiaries
Avadel Pharmaceuticals Plc, Key Competitors
Avadel Pharmaceuticals Plc, Ratios based on current share price
Avadel Pharmaceuticals Plc, Annual Ratios
Avadel Pharmaceuticals Plc, Annual Ratios (Cont...1)
Avadel Pharmaceuticals Plc, Annual Ratios (Cont...2)
Avadel Pharmaceuticals Plc, Interim Ratios
Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Avadel Pharmaceuticals Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Avadel Pharmaceuticals Plc, Performance Chart (2015 - 2019)
Avadel Pharmaceuticals Plc, Ratio Charts
Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Avadel Pharmaceuticals Plc (AVDL):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • TE Connectivity Ltd (TEL):電力:M&Aディール及び事業提携情報
    Summary TE Connectivity Ltd (TE Connectivity), formerly Tyco Electronics Ltd, is a technology company. It designs and manufactures connectivity and sensor solutions. The company offers connectors; sensors; relays; heat shrink tubing; wire and cable; antennas and circuit protection devices. Its solut …
  • Agilent Technologies Inc (A):企業の財務・戦略的SWOT分析
    Agilent Technologies Inc (A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Staatsolie Maatschappij Suriname NV:企業の戦略的SWOT分析
    Staatsolie Maatschappij Suriname NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • TechnologyOne Limited (TNE):企業の財務・戦略的SWOT分析
    TechnologyOne Limited (TNE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • LeMaitre Vascular Inc (LMAT):製品パイプライン分析
    Summary LeMaitre Vascular Inc (LeMaitre Vascular) is a medical device company. It undertakes the development, manufacture, marketing and sale of devices that are used in the treatment of peripheral vascular diseases. The company offers several product lines for vascular surgery and endovascular proc …
  • Nuvelution Pharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Nuvelution Pharma Inc (Nuvelution Pharma) is a developer of late-stage clinical assets. The company offers research and development risk-sharing approach to pharmaceutical and biotechnology companies. It facilitates advancement of late-stage clinical assets where research and development bud …
  • Gencor Industries Inc (GENC):企業の財務・戦略的SWOT分析
    Gencor Industries Inc (GENC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Haworth Inc:企業の戦略的SWOT分析
    Haworth Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Huron Consulting Group Inc:企業のM&A・事業提携・投資動向
    Huron Consulting Group Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Huron Consulting Group Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Huaneng Power International Inc (600011):電力:M&Aディール及び事業提携情報
    Summary Huaneng Power International, Inc. (HPI) a subsidiary of Huaneng International Power Development Corporation is an independent power producer. The company together with its subsidiaries develops, constructs, operates and manages large thermal and hydro power plants in China. It owns a wholly- …
  • Mediq N.V.:企業の戦略・SWOT・財務情報
    Mediq N.V. - Strategy, SWOT and Corporate Finance Report Summary Mediq N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Avid Technology Inc (AVID):企業の財務・戦略的SWOT分析
    Avid Technology Inc (AVID) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Novan Inc (NOVN):製薬・医療:M&Aディール及び事業提携情報
    Summary Novan Inc (Novan) is a clinical-stage pharmaceutical company that develops nitric oxide therapies for the treatment of dermatological and oncovirus-mediated diseases. The company’s pipeline products are being developed for the treatment of acne vulgaris; genital warts; for onychomycosis and …
  • Atomic Energy of Canada Ltd:企業の戦略的SWOT分析
    Atomic Energy of Canada Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • The Stars Group Inc (TSGI):企業の財務・戦略的SWOT分析
    The Stars Group Inc (TSGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Endotronix Inc:医療機器:M&Aディール及び事業提携情報
    Summary Endotronix Inc (Endotronix) is a medical technology company that offers digital health solutions. The company offers Cordella Heart Failure System with an implantable wireless pulmonary artery sensor for early detection of worsening heart failure. Endotronix’s solution includes an implanted …
  • Superdry Plc:企業の戦略・SWOT・財務分析
    Superdry Plc - Strategy, SWOT and Corporate Finance Report Summary Superdry Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Dubai Electricity and Water Authority:企業の戦略的SWOT分析
    Dubai Electricity and Water Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • NuSirt Biopharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary NuSirt Biopharma Inc (NuSirt Sciences) develops a technology platform that combines natural compounds with various pharmaceutical agents to prevent and treat chronic diseases resulting from over-nutrition and aging. Its technology platform focuses on activating sirtuin pathways through the a …
  • Petroleos de Venezuela SA:石油・ガス:M&Aディール及び事業提携情報
    Summary Petroleos de Venezuela SA (PDVSA) is a state-owned oil and gas company. It plans, coordinates, supervises, and controls the activities in the entire oil and gas value chain. The company explores for and develops oil and other hydrocarbons; refines, trades, and supplies that in domestic and o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆